title: Nuclear factor-kappaB and advanced glycation end-products expression in lacrimal glands of aging rats.
abstract: Advanced glycation end products (AGEs) increase with aging and induce signaling alterations that lead to inflammation and dysfunction in several tissues. Aging reduces function and insulin signaling in lacrimal glands (LGs). To evaluate whether AGE signaling and insulin secretion in LGs are altered in aging, 24- and 2-month-old male Wistar rats were compared. Immunohistochemistry with confocal microscopy was used to evaluate AGE, AGE receptor (RAGE) and nuclear factor-kappaB (NF-kappaB) expression in LGs. Basal tear secretion volume, insulin, interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) levels in tears and LGs and peroxidase activity in LG tissue were measured. Insulin secretion from isolated LGs and pancreatic beta-cells was compared in the supernatant of aging and control rats in vitro by RIA after stimulation with 2.8-16.7 mM glucose, carbachol and KCl. AGE, RAGE and NF-kappaB expression was higher in LGs of aging compared with young rats. Basal tear secretion and peroxidase activity were significantly lower in the aging group (P=0.016 for both assays). IL-1beta and TNF-alpha levels were higher in tears of aging rats compared with young rats (P=0.007 and 0.05 respectively); however, even though aging rats were insulin-resistant (as confirmed by the insulin-tolerance test), the insulin levels in the tear film of aging and control rats were similar in vivo and in vitro. The higher expression of AGEs, RAGE and NF-kappaB in LGs of aging rats is accompanied by systemic insulin resistance and may be involved in LG and tear film alterations but does not affect insulin secretion in the tear film. These observations indicate that metabolic events may be related to LG and tear film dysfunctions in aging.
authors.affiliation: Laboratory of Clinical Physiopathology, Department of Clinical Medicine, School of Medicine, State University of Campinas (UNICAMP), Campinas, Brazil.
authors.forename: M
authors.initials: M
authors.lastname: Alves
authors.forename: D Andrade
authors.initials: DA
authors.lastname: Cunha
authors.forename: V Cristine
authors.initials: VC
authors.lastname: Calegari
authors.forename: M J A
authors.initials: MJ
authors.lastname: Saad
authors.forename: A Carlos
authors.initials: AC
authors.lastname: Boschero
authors.forename: L Augusto
authors.initials: LA
authors.lastname: Velloso
authors.forename: E Melani
authors.initials: EM
authors.lastname: Rocha
mesh_terms: D000375:Aging / Q000502:physiology*; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D017127:Glycation End Products, Advanced / Q000032:analysis* / Q000378:metabolism; D007150:Immunohistochemistry / Q000379:methods; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007375:Interleukin-1 / Q000032:analysis; D007765:Lacrimal Apparatus / Q000378:metabolism*; D008297:Male; D018613:Microscopy, Confocal; D008916:Miotics / Q000494:pharmacology; D016328:NF-kappa B / Q000032:analysis* / Q000378:metabolism; D009924:Organ Culture Techniques; D010179:Pancreas / Q000378:metabolism; D009195:Peroxidase / Q000032:analysis / Q000378:metabolism; D011189:Potassium Chloride / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000032:analysis; D015398:Signal Transduction / Q000502:physiology; D013666:Tears / Q000737:chemistry / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
chemical_list: D017127:Glycation End Products, Advanced; D007328:Insulin; D007375:Interleukin-1; D008916:Miotics; D016328:NF-kappa B; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic; D014409:Tumor Necrosis Factor-alpha; D011189:Potassium Chloride; D002217:Carbachol; D009195:Peroxidase; D005947:Glucose